| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |